Related Experiment Video
Updated: Aug 17, 2026

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
[Salmonella of Indian origin: pseudo-susceptibility to fluoroquinolones]
E Denes1, G Gondran, H Bezanahary
1Service des maladies infectieuses et tropicales, CHU Dupuytren, 2, avenue Martin-Luther-King, 87042 Limoges cedex, France. eric.denes@unilim.fr
Abstract:
We report the case of a patient presenting with typhoid fever after returning from a stay in India. This infection was not cured with a course of ciprofloxacin, due to a reduced susceptibility of the bacteria to the drug. This decreased susceptibility to fluoroquinolones was not detected by the antibiogram, but the MIC for nalidixic acid was greater than 32 mg/l. This case suggests using a third generation cephalosporin instead of a quinolone, for people coming from a high-risk zone. It also suggests that the MIC for nalidixic acid and for norfloxacin can be used as the first clue for a reduced susceptibility to fluoroquinolones.
Insights
A typhoid fever case in India resistant to ciprofloxacin highlights fluoroquinolone resistance. Nalidixic acid MIC may predict resistance, suggesting alternative antibiotics for travelers.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Typhoid fever is a significant global health concern, particularly in endemic regions like India.
- Fluoroquinolones are commonly prescribed for typhoid fever, but antimicrobial resistance is a growing challenge.
Observation:
- A patient returning from India developed typhoid fever unresponsive to ciprofloxacin treatment.
- Standard antibiogram did not detect reduced susceptibility, but a high Minimum Inhibitory Concentration (MIC) for nalidixic acid (>32 mg/l) was noted.
Findings:
- The typhoid-causing bacteria exhibited reduced susceptibility to fluoroquinolones, a resistance not identified by routine testing.
- Elevated MIC for nalidixic acid and norfloxacin can serve as early indicators of fluoroquinolone resistance.
Implications:
- For travelers from high-risk areas, consider third-generation cephalosporins over fluoroquinolones for typhoid treatment.
- Implementing MIC testing for nalidixic acid and norfloxacin could improve early detection of fluoroquinolone resistance in Salmonella Typhi.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Reservoir of Infection
Gene Regulation in Microbial Communities: Quorum Sensing
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
